scholarly article | Q13442814 |
P356 | DOI | 10.1097/00006250-199011000-00001 |
P698 | PubMed publication ID | 2216215 |
P2093 | author name string | Files JC | |
Martin JN Jr | |||
Morrison JC | |||
Blake PG | |||
Perry KG Jr | |||
Lowry SL | |||
P433 | issue | 5 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
postpartum period | Q749115 | ||
P304 | page(s) | 737-741 | |
P577 | publication date | 1990-11-01 | |
P1433 | published in | Obstetrics and Gynecology | Q7075543 |
P1476 | title | Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? | |
P478 | volume | 76 |
Q33419827 | A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange |
Q44047707 | Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia |
Q46331247 | An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome? |
Q33377704 | Characteristic laboratory changes in pregnancies complicated by HELLP syndrome |
Q31125913 | Clinical and biophysical aspects of HELLP-syndrome |
Q34393266 | Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. |
Q37769887 | Coagulation abnormalities and obstetric anaesthesia |
Q35089308 | Correlation of platelet count changes with liver cell destruction in HELLP syndrome |
Q36354667 | Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis. |
Q44356806 | Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome |
Q74256302 | Dexamethasone in the post-partum treatment of HELLP syndrome |
Q33329194 | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity |
Q74695886 | Effects of postpartum corticosteroids in patients with HELLP syndrome |
Q45346988 | Factor V Leiden mutation and pregnancy-related complications |
Q72516894 | Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets) |
Q44628201 | HELLP Syndrome: 8 Years of Experience from a Tertiary Referral Center in Western Turkey |
Q33334624 | HELLP syndrome |
Q72548858 | HELLP syndrome and coagulopathies of pregnancy |
Q33681889 | HELLP syndrome: mechanisms and management |
Q35885406 | HELLP syndrome: report of 61 cases and literature review |
Q38079635 | Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system |
Q40593286 | Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital |
Q46357265 | Is conservative treatment of HELLP syndrome safe? |
Q47857696 | Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? |
Q33333589 | Management of idiopathic thrombocytopenic purpura in pregnancy |
Q33406627 | Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). |
Q46357134 | Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? |
Q46317231 | Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes |
Q73466967 | Partial necrosis of cervix uteri as a complication to HELLP-syndrome |
Q51926830 | Physical well-being in women with a history of severe preeclampsia. |
Q33400905 | Platelet counts and coagulation tests prior to neuraxial anesthesia in patients with preeclampsia: a retrospective analysis |
Q30435894 | Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications |
Q33499076 | Postpartum recovery after severe pre-eclampsia and HELLP-syndrome |
Q73366514 | Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome |
Q37078953 | Pregnancy-associated liver disorders |
Q34025583 | Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. |
Q21261342 | The HELLP syndrome: clinical issues and management. A Review |
Q44487400 | The evaluation of maternal parameters at diagnosis may predict HELLP syndrome severity |
Q46344580 | The role of plasma exchange in HELLP syndrome. |
Q33864822 | The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification |
Q33337048 | Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone |
Q40493720 | Use of Nifedipine in the Hypertensive Diseases of Pregnancy |
Q46353718 | [Maternal and perinatal morbidity and mortality associated with hellp syndrome] . |
Search more.